PTON is in an uptrend with no signs of selling.
TheStreet's quantitative service gives a buy recommendation for Align Technologies and it looks like a dip could be an opportunity for investors.
After finding success in treatment for epilepsy and other conditions, some in the industry are focusing on autism spectrum disorder.
The 'stay-at-home stock' rallied on Wednesday.
Let's check out the charts of this plasma transfusion company.
RAD seems to be off everyone's radar and that makes it more interesting to me.
The Fed and Treasury are set on avoiding the mistakes that doomed us in the past, and we have to invest for this new market we're in now.
The stock has formed a bearish engulfing pattern.
Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.
The medical device company is scheduled to report earnings this week.